The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance

The study of the calpain and caspase-1 expression in ultrastructural dynamics of Ehrlich ascites carcinoma necrosis

(2018) Arkadiy Reunov et al.   GENE

SPP1 promotes ovarian cancer progression via Integrin β1/FAK/Akt signaling pathway

(2018) Biao zeng et al.   OncoTargets and Therapy

Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer

(2017) Rehman Ata et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy

(2017) Tianchi Yu et al.   YONSEI MEDICAL JOURNAL

Exosomes as mediators of platinum resistance in ovarian cancer

(2017) Jennifer Crow et al.   Oncotarget

Transfer of microRNA-486-5p from human endothelial colony forming cell–derived exosomes reduces ischemic kidney injury

(2016) Jose L. Viñas et al.   KIDNEY INTERNATIONAL

Extracellular vesicles round off communication in the nervous system

(2016) Vivian Budnik et al.   NATURE REVIEWS NEUROSCIENCE

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1

(2016) Chi Lam Au Yeung et al.   Nature Communications

Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells

(2016) Lana Bruney et al.   Oncotarget

Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer

(2016) Natividad Gomez-Roman et al.   Oncotarget

Human Endothelial Colony-Forming Cells Protect against Acute Kidney Injury

(2015) Dylan Burger et al.   AMERICAN JOURNAL OF PATHOLOGY

The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells

(2015) Ryan Charles Pink et al.   GYNECOLOGIC ONCOLOGY

Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence

(2015) Christina Wefers et al.   GYNECOLOGIC ONCOLOGY

Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)

(2015) GEORGE MIHAI NITULESCU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68

(2015) Kiran Kumar Nakka et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The prognostic value of phosphorylated Akt in breast cancer: a systematic review

(2015) Zu-Yao Yang et al.   Scientific Reports

Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer

(2015) Dimitra T. Stefanou et al.   PLoS One

Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells

(2014) Yifang Wei et al.   BREAST CANCER RESEARCH AND TREATMENT

Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer

(2014) Pei-Wen Wang et al.   INTERNATIONAL JOURNAL OF CANCER

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus

(2014) Pengda Liu et al.   NATURE

Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs

(2014) Wei-xian Chen et al.   PLoS One

Cell fate regulation by gelsolin in human gynecologic cancers

(2014) Mohammad R. Abedini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Exosome in Tumour Microenvironment: Overview of the Crosstalk between Normal and Cancer Cells

(2014) Catarina Roma-Rodrigues et al.   Biomed Research International

Transcriptional regulation by hypoxia inducible factors

(2013) Veronica L. Dengler et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Inhibition of Protein Synthesis Alters Protein Degradation through Activation of Protein Kinase B (AKT)

(2013) Chun-Ling Dai et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Microenvironmental regulation of tumor progression and metastasis

(2013) Daniela F Quail et al.   NATURE MEDICINE

Investigation of the hub genes and related mechanism in ovarian cancer via bioinformatics analysis

(2013) Ling-jie Fu et al.   Journal of Ovarian Research

Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients

(2012) Balázs Győrffy et al.   ENDOCRINE-RELATED CANCER

Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients

(2011) Jie Yin et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer

(2011) Ming-Hung Tsai et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation

(2011) A Y Ali et al.   ONCOGENE

Akt inhibitors in clinical development for the treatment of cancer

(2010) Sumanta Kumar Pal et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrin

(2009) Miyuki Bohgaki et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein

(2009) M R Abedini et al.   ONCOGENE

Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical study

(2008) Alexandros Daponte et al.   BMC CANCER